Structure of Mexiletine HCl
CAS No.: 5370-01-4
*Storage: {[sel_prStorage]}
*Shipping: {[sel_prShipping]}
The BI-3802 was designed by Boehringer Ingelheim and could be obtained free of charge through the Boehringer Ingelheim open innovation portal opnMe.com, associated with its negative control.
Mexiletine HCl is a non-selective blocker of voltage-gated sodium channel. It blongs to the anti-arrhythmic compounds of class IB .
Synonyms: KOE-1173 hydrochloride; Mexiletine(hydrochloride); Ko 1173
4.5
*For Research Use Only !
Change View
| Size | Price | VIP Price |
DE Stock US Stock |
Asia Stock Global Stock |
In Stock |
| {[ item.pr_size ]} |
Inquiry
{[ getRatePrice(item.pr_usd, 1,1,item.pr_is_large_size_no_price, item.pr_usd) ]} {[ getRatePrice(item.pr_usd,item.pr_rate,1,item.pr_is_large_size_no_price, item.discount_usd) ]} {[ getRatePrice(item.pr_usd, 1,1,item.pr_is_large_size_no_price, item.pr_usd) ]} |
Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]} | {[ item.p_spot_brand_remark ]} 1-2 weeks {[ item.pr_usastock ]} In Stock Inquiry - | {[ item.p_spot_brand_remark ]} 1-2 weeks {[ item.pr_chinastock ]} {[ item.pr_remark ]} In Stock Inquiry - | Login - + |
Please Login or Create an Account to: See VIP prices and availability
Asia Stock: Ship in 3-5 business days
EU Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days
US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days
{[ item.p_spot_brand_remark ]}
1-2weeks
Inquiry
Inquiry
{[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}
{[ getRatePrice(item.pr_usd, 1,1,item.pr_is_large_size_no_price, item.pr_usd) ]}
{[ getRatePrice(item.pr_usd,1,item.mem_rate,item.pr_is_large_size_no_price, item.pr_usd) ]}
{[ item.p_spot_brand_remark ]}
1-2weeks
Inquiry
Inquiry
{[ getRatePrice(item.pr_usd,item.pr_rate,1,item.pr_is_large_size_no_price, item.vip_usd) ]}
{[ getRatePrice(item.pr_usd, 1,1,item.pr_is_large_size_no_price, item.pr_usd) ]}
{[ getRatePrice(item.pr_usd, 1,1,item.pr_is_large_size_no_price, item.pr_usd) ]}
In Stock
- +
Please Login or Create an Account to: See VIP prices and availability
Asia Stock: Ship in 3-5 business days
EU Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days
US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days
Search for reports by entering the product batch number.
Batch number can be found on the product's label following the word 'Batch'.
Search for reports by entering the product batch number.
Batch number can be found on the product's label following the word 'Batch'.
Search for reports by entering the product batch number.
Batch number can be found on the product's label following the word 'Batch'.
Search for reports by entering the product batch number.
Batch number can be found on the product's label following the word 'Batch'.
Search for reports by entering the product batch number.
Batch number can be found on the product's label following the word 'Batch'.
| CAS No. : | 5370-01-4 |
| Formula : | C11H18ClNO |
| M.W : | 215.72 |
| SMILES Code : | CC(N)COC1=C(C)C=CC=C1C.[H]Cl |
| Synonyms : |
KOE-1173 hydrochloride; Mexiletine(hydrochloride); Ko 1173
|
| MDL No. : | MFCD00216024 |
| InChI Key : | NFEIBWMZVIVJLQ-UHFFFAOYSA-N |
| Pubchem ID : | 21467 |
| GHS Pictogram: |
|
| Signal Word: | Warning |
| Hazard Statements: | H302-H315-H319 |
| Precautionary Statements: | P261-P305+P351+P338 |
| Description |
Mexiletine is an orally effective antiarrhythmic agent noted for its benefits in treating myotonia and neuropathic pain. It operates by inhibiting sodium channels, with an IC50 of 75±8 μM for tonic block and 23.6±2.8 μM for use-dependent block, making it relevant for both cardiovascular and neurological research[1].[2].[3].[4].[5].
|
| Target |
|
In Vitro:
|
Cell Line
|
Concentration | Treated Time | Description | References |
| Casq2−/− myocytes | 100 μM | 10 min | Mexiletine had no significant effects on Ca2+ wave parameters at the highest concentration tested (100 μM) | J Mol Cell Cardiol. 2011 Nov;51(5):760-8 |
| Mouse cardiomyocytes | 100–1,000 µM | 3 minutes | Evaluate the inhibitory effect of JME-173 on L-type Ca++ currents, finding it was 12-fold more potent than Mexiletine | Front Pharmacol. 2020 Jul 30;11:1159 |
| GH3 cells | 0.28 mM | Evaluate the blocking effect of JME-173 on Na+ channels, finding its potency to block Na+ currents was 653-fold lower than Mexiletine | Front Pharmacol. 2020 Jul 30;11:1159 | |
| Casq2−/− cardiomyocytes | 6 μmol/L | 30 minutes | Mexiletine had no significant effect on isoproterenol-induced spontaneous Ca2+ waves | Circ Arrhythm Electrophysiol. 2011 Apr;4(2):128-35 |
| ClCadr muscle fibers | 10, 25, 50, 100 μM | To evaluate the effect of Mexiletine on the excitability of ClCadr muscle fibers. At 10 and 25 μM, most fibers remained hyperexcitable; at 50 μM, there was a wide range in excitability; and at 100 μM, almost all fibers were hypoexcitable. | Ann Neurol. 2015 Feb;77(2):320-32 | |
| ADR mouse skeletal muscle fibers | 30 μM | 30 minutes | To evaluate the antimyotonic effects of Mexiletine on sarcolemma excitability in ADR mouse skeletal muscle fibers. Mexiletine at 30 μM reduced the number of action potentials, with effects comparable to 10 μM sa finamide. | Neurotherapeutics. 2024 Oct;21(6):e00455 |
| ADR mouse skeletal muscle fibers | 10 μM | 30 minutes | To evaluate the antimyotonic effects of Mexiletine on sarcolemma excitability in ADR mouse skeletal muscle fibers. Mexiletine at 10 μM reduced the number of action potentials by 24.4%. | Neurotherapeutics. 2024 Oct;21(6):e00455 |
| Rat tracheal rings | 10–100 µM | 15 minutes | Assess the inhibitory effect of JME-173 on carbachol-induced tracheal contraction, finding JME-173 was 15-fold more potent than Mexiletine | Front Pharmacol. 2020 Jul 30;11:1159 |
In Vivo:
|
Species
|
Animal Model
|
Administration | Dosage | Frequency | Description | References |
| C57BL/6J mice | Cisplatin or oxaliplatin-induced neuropathy model | Intraperitoneal injection | 10 mg/kg | Single dose, assessed 1 hour after administration | To evaluate the analgesic effects of mexiletine on cisplatin or oxaliplatin-induced neuropathy, results showed mexiletine was ineffective in both models | Neuro Oncol. 2014 Oct;16(10):1324-32 |
| Mice | TGM(NS31)L12 transgenic mice | Intraperitoneal injection | 25 mg/kg | Twice daily for 14 days | To evaluate the effect of mexiletine on arrhythmias, results showed that mexiletine significantly suppressed spontaneous VT/VF in transgenic mice | Cardiovasc Res. 2004 Feb 1;61(2):256-67 |
| Mice | Mouse model of myotonia congenita | Intraperitoneal injection | 5, 10, 20, 40 mg/kg | Single injection, effects evaluated at 5 to 15 minutes | To evaluate the effect of Mexiletine on motor function in a mouse model of myotonia congenita. Mexiletine at 20 mg/kg significantly improved motor function, but at 40 mg/kg, mild ataxia was observed. | Ann Neurol. 2015 Feb;77(2):320-32 |
| ADR mice | Myotonia model | Intraperitoneal injection | 10 mg/kg | Single administration, effects measured over 120 minutes | To evaluate the in vivo antimyotonic effects of Mexiletine in ADR mice. Mexiletine at 10 mg/kg significantly reduced TRR, but was less potent than sa finamide. | Neurotherapeutics. 2024 Oct;21(6):e00455 |
| Mice | AMPA-induced lethality model | Subcutaneous injection | 24.5 – 81.5 mg/kg s.c. | Single dose | Mexiletine partially protected mice against AMPA-induced lethality with a maximum effect of 30-60%. | Br J Pharmacol. 2001 Jul;133(6):789-96 |
| Mice | Trpm4 knockout mice | Langendorff perfusion | 40 µg/mL | Single dose, 20 minutes duration | To study the effect of Mexiletine on cardiac electrical activity in Trpm4?/? mice, results showed that Trpm4?/? hearts were more sensitive to Mexiletine with more pronounced QRS broadening. | Int J Mol Sci. 2021 Mar 26;22(7):3401 |
Clinical Trial:
| NCT Number | Conditions | Phases | Recruitment | Completion Date | Locations |
| NCT02308748 | Drug-induced QT Prolongation ... More >> Pharmacokinetics Pharmacodynamics Less << | Phase 1 | Completed | - | - |
| NCT02336477 | Non-dystrophic Myotonias ... More >> Paramyotonia Congenita Myotonia Congenita Less << | Phase 3 | Completed | - | France ... More >> Groupe Hospitalier Pitié Salpetriere Paris, France, 75013 Less << |
| NCT02045667 | Non Dystrophic Myotonia | Phase 2 | Completed | - | Netherlands ... More >> Departments of Neurology, Radboud University Nijmegen Medical Centre, the Netherlands Nijmegen, Gelderland, Netherlands, 6500HB Less << |
| NCT02308748 | - | Completed | - | - | |
| NCT01849770 | Sporadic Amyotrophic Lateral S... More >>clerosis Less << | Phase 2 | Completed | - | United States, California ... More >> UCLA, Neuromuscular Research Center Los Angeles, California, United States, 90095 United States, Iowa University of Iowa Iowa City, Iowa, United States, 52242 United States, Kansas University of Kansas Medical Center Kansas City, Kansas, United States, 66160 United States, Massachusetts Massachusetts General Hospital Boston, Massachusetts, United States, 02114 University of Massachusetts (Worcester) Memorial Medical Center Worcester, Massachusetts, United States, 01655 United States, Missouri Washington University Medical School Saint Louis, Missouri, United States, 63110 United States, New York SUNY Upstate Medical Center Syracuse, New York, United States, 13210 United States, Pennsylvania Penn State Hershey Medical Center Hershey, Pennsylvania, United States, 17033 United States, Texas University of Texas Southwestern Medical Center at Dallas Dallas, Texas, United States, 75390-8897 United States, Washington University of Washington Medical Center Seattle, Washington, United States, 98195 Less << |
| NCT02114528 | Ventricular Tachycardia ... More >> Ventricular Arrhythmia Less << | Phase 4 | Terminated(Low recruitment. Pi... More >>lot trial.) Less << | - | Canada, Ontario ... More >> University of Ottawa Heart Institute Ottawa, Ontario, Canada, K1Y 4W7 Less << |
| NCT01849770 | - | Completed | - | - | |
| NCT01406873 | Myotonic Dystrophy | Phase 2 | Completed | - | United States, New York ... More >> University of Rochester Medical Center, Department of Neurology Rochester, New York, United States, 14642 Less << |
| NCT01406873 | - | Completed | - | - | |
| NCT02781454 | Sporadic Amyotrophic Lateral S... More >>clerosis Less << | Phase 2 | Active, not recruiting | December 31, 2018 | United States, Arizona ... More >> Barrow Neurological Institute Phoenix, Arizona, United States, 85013 United States, California University of California, Irvine Orange, California, United States, 92868 United States, Georgia Augusta University Augusta, Georgia, United States, 30912 United States, Massachusetts Beth Israel Deaconess Medical Center Boston, Massachusetts, United States, 02215 United States, Michigan University of Michigan Ann Arbor, Michigan, United States, 48109 United States, New York Columbia Universtiy Medical Center New York, New York, United States, 10032 United States, Pennsylvania Pennsylvania State Hershey Medical Center Hershey, Pennsylvania, United States, 17033 University of Pittsburgh Pittsburgh, Pennsylvania, United States, 15213 United States, South Carolina Medical University of South Carolina Charleston, South Carolina, United States, 29425 United States, Washington University of Washington Seattle, Washington, United States, 98195 Less << |
| NCT00000793 | HIV Infections ... More >> Peripheral Nervous System Disease Less << | Phase 2 | Completed | - | - |
| Bio Calculators | ||||
| Preparing Stock Solutions | ![]() |
1mg | 5mg | 10mg |
|
1 mM 5 mM 10 mM |
4.64mL 0.93mL 0.46mL |
23.18mL 4.64mL 2.32mL |
46.36mL 9.27mL 4.64mL |
|
| Dissolving Methods |
Please choose the appropriate dissolution scheme according to your animal administration guide.For the following dissolution schemes, clear stock solution should be prepared according to in vitro experiments, and then cosolvent should be added in turn:
in order to ensure the reliability of the experimental results, the clarified stock solution can be properly preserved according to the storage conditions; The working fluid for in vivo experiment is recommended to be prepared now and used on the same day; The percentage shown in front of the following solvent refers to the volume ratio of the solvent in the final solution; If precipitation or precipitation occurs in the preparation process, it can be assisted by heating and/or ultrasound.
|
|||
Tags: Mexiletine | KOE-1173 | KOE1173 | KOE 1173 | Sodium Channel | Na channels | Na+ channels | antiarrhythmic | Class IB | myocardial | ischemia | myotonia | neuropathic pain | sodium channel | cardiovascular | neurological | HEK293A | hiPSC-CMs | 5370-01-4 |
Precautionary Statements-General | |
| Code | Phrase |
| P101 | If medical advice is needed,have product container or label at hand. |
| P102 | Keep out of reach of children. |
| P103 | Read label before use |
Prevention | |
| Code | Phrase |
| P201 | Obtain special instructions before use. |
| P202 | Do not handle until all safety precautions have been read and understood. |
| P210 | Keep away from heat/sparks/open flames/hot surfaces. - No smoking. |
| P211 | Do not spray on an open flame or other ignition source. |
| P220 | Keep/Store away from clothing/combustible materials. |
| P221 | Take any precaution to avoid mixing with combustibles |
| P222 | Do not allow contact with air. |
| P223 | Keep away from any possible contact with water, because of violent reaction and possible flash fire. |
| P230 | Keep wetted |
| P231 | Handle under inert gas. |
| P232 | Protect from moisture. |
| P233 | Keep container tightly closed. |
| P234 | Keep only in original container. |
| P235 | Keep cool |
| P240 | Ground/bond container and receiving equipment. |
| P241 | Use explosion-proof electrical/ventilating/lighting/equipment. |
| P242 | Use only non-sparking tools. |
| P243 | Take precautionary measures against static discharge. |
| P244 | Keep reduction valves free from grease and oil. |
| P250 | Do not subject to grinding/shock/friction. |
| P251 | Pressurized container: Do not pierce or burn, even after use. |
| P260 | Do not breathe dust/fume/gas/mist/vapours/spray. |
| P261 | Avoid breathing dust/fume/gas/mist/vapours/spray. |
| P262 | Do not get in eyes, on skin, or on clothing. |
| P263 | Avoid contact during pregnancy/while nursing. |
| P264 | Wash hands thoroughly after handling. |
| P265 | Wash skin thouroughly after handling. |
| P270 | Do not eat, drink or smoke when using this product. |
| P271 | Use only outdoors or in a well-ventilated area. |
| P272 | Contaminated work clothing should not be allowed out of the workplace. |
| P273 | Avoid release to the environment. |
| P280 | Wear protective gloves/protective clothing/eye protection/face protection. |
| P281 | Use personal protective equipment as required. |
| P282 | Wear cold insulating gloves/face shield/eye protection. |
| P283 | Wear fire/flame resistant/retardant clothing. |
| P284 | Wear respiratory protection. |
| P285 | In case of inadequate ventilation wear respiratory protection. |
| P231 + P232 | Handle under inert gas. Protect from moisture. |
| P235 + P410 | Keep cool. Protect from sunlight. |
Response | |
| Code | Phrase |
| P301 | IF SWALLOWED: |
| P304 | IF INHALED: |
| P305 | IF IN EYES: |
| P306 | IF ON CLOTHING: |
| P307 | IF exposed: |
| P308 | IF exposed or concerned: |
| P309 | IF exposed or if you feel unwell: |
| P310 | Immediately call a POISON CENTER or doctor/physician. |
| P311 | Call a POISON CENTER or doctor/physician. |
| P312 | Call a POISON CENTER or doctor/physician if you feel unwell. |
| P313 | Get medical advice/attention. |
| P314 | Get medical advice/attention if you feel unwell. |
| P315 | Get immediate medical advice/attention. |
| P320 | |
| P302 + P352 | IF ON SKIN: wash with plenty of soap and water. |
| P321 | |
| P322 | |
| P330 | Rinse mouth. |
| P331 | Do NOT induce vomiting. |
| P332 | IF SKIN irritation occurs: |
| P333 | If skin irritation or rash occurs: |
| P334 | Immerse in cool water/wrap n wet bandages. |
| P335 | Brush off loose particles from skin. |
| P336 | Thaw frosted parts with lukewarm water. Do not rub affected area. |
| P337 | If eye irritation persists: |
| P338 | Remove contact lenses, if present and easy to do. Continue rinsing. |
| P340 | Remove victim to fresh air and keep at rest in a position comfortable for breathing. |
| P341 | If breathing is difficult, remove victim to fresh air and keep at rest in a position comfortable for breathing. |
| P342 | If experiencing respiratory symptoms: |
| P350 | Gently wash with plenty of soap and water. |
| P351 | Rinse cautiously with water for several minutes. |
| P352 | Wash with plenty of soap and water. |
| P353 | Rinse skin with water/shower. |
| P360 | Rinse immediately contaminated clothing and skin with plenty of water before removing clothes. |
| P361 | Remove/Take off immediately all contaminated clothing. |
| P362 | Take off contaminated clothing and wash before reuse. |
| P363 | Wash contaminated clothing before reuse. |
| P370 | In case of fire: |
| P371 | In case of major fire and large quantities: |
| P372 | Explosion risk in case of fire. |
| P373 | DO NOT fight fire when fire reaches explosives. |
| P374 | Fight fire with normal precautions from a reasonable distance. |
| P376 | Stop leak if safe to do so. Oxidising gases (section 2.4) 1 |
| P377 | Leaking gas fire: Do not extinguish, unless leak can be stopped safely. |
| P378 | |
| P380 | Evacuate area. |
| P381 | Eliminate all ignition sources if safe to do so. |
| P390 | Absorb spillage to prevent material damage. |
| P391 | Collect spillage. Hazardous to the aquatic environment |
| P301 + P310 | IF SWALLOWED: Immediately call a POISON CENTER or doctor/physician. |
| P301 + P312 | IF SWALLOWED: call a POISON CENTER or doctor/physician IF you feel unwell. |
| P301 + P330 + P331 | IF SWALLOWED: Rinse mouth. Do NOT induce vomiting. |
| P302 + P334 | IF ON SKIN: Immerse in cool water/wrap in wet bandages. |
| P302 + P350 | IF ON SKIN: Gently wash with plenty of soap and water. |
| P303 + P361 + P353 | IF ON SKIN (or hair): Remove/Take off Immediately all contaminated clothing. Rinse SKIN with water/shower. |
| P304 + P312 | IF INHALED: Call a POISON CENTER or doctor/physician if you feel unwell. |
| P304 + P340 | IF INHALED: Remove victim to fresh air and Keep at rest in a position comfortable for breathing. |
| P304 + P341 | IF INHALED: If breathing is difficult, remove victim to fresh air and keep at rest in a position comfortable for breathing. |
| P305 + P351 + P338 | IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing. |
| P306 + P360 | IF ON CLOTHING: Rinse Immediately contaminated CLOTHING and SKIN with plenty of water before removing clothes. |
| P307 + P311 | IF exposed: call a POISON CENTER or doctor/physician. |
| P308 + P313 | IF exposed or concerned: Get medical advice/attention. |
| P309 + P311 | IF exposed or if you feel unwell: call a POISON CENTER or doctor/physician. |
| P332 + P313 | IF SKIN irritation occurs: Get medical advice/attention. |
| P333 + P313 | IF SKIN irritation or rash occurs: Get medical advice/attention. |
| P335 + P334 | Brush off loose particles from skin. Immerse in cool water/wrap in wet bandages. |
| P337 + P313 | IF eye irritation persists: Get medical advice/attention. |
| P342 + P311 | IF experiencing respiratory symptoms: call a POISON CENTER or doctor/physician. |
| P370 + P376 | In case of fire: Stop leak if safe to Do so. |
| P370 + P378 | In case of fire: |
| P370 + P380 | In case of fire: Evacuate area. |
| P370 + P380 + P375 | In case of fire: Evacuate area. Fight fire remotely due to the risk of explosion. |
| P371 + P380 + P375 | In case of major fire and large quantities: Evacuate area. Fight fire remotely due to the risk of explosion. |
Storage | |
| Code | Phrase |
| P401 | |
| P402 | Store in a dry place. |
| P403 | Store in a well-ventilated place. |
| P404 | Store in a closed container. |
| P405 | Store locked up. |
| P406 | Store in corrosive resistant/ container with a resistant inner liner. |
| P407 | Maintain air gap between stacks/pallets. |
| P410 | Protect from sunlight. |
| P411 | |
| P412 | Do not expose to temperatures exceeding 50 oC/ 122 oF. |
| P413 | |
| P420 | Store away from other materials. |
| P422 | |
| P402 + P404 | Store in a dry place. Store in a closed container. |
| P403 + P233 | Store in a well-ventilated place. Keep container tightly closed. |
| P403 + P235 | Store in a well-ventilated place. Keep cool. |
| P410 + P403 | Protect from sunlight. Store in a well-ventilated place. |
| P410 + P412 | Protect from sunlight. Do not expose to temperatures exceeding 50 oC/122oF. |
| P411 + P235 | Keep cool. |
Disposal | |
| Code | Phrase |
| P501 | Dispose of contents/container to ... |
| P502 | Refer to manufacturer/supplier for information on recovery/recycling |
Physical hazards | |
| Code | Phrase |
| H200 | Unstable explosive |
| H201 | Explosive; mass explosion hazard |
| H202 | Explosive; severe projection hazard |
| H203 | Explosive; fire, blast or projection hazard |
| H204 | Fire or projection hazard |
| H205 | May mass explode in fire |
| H220 | Extremely flammable gas |
| H221 | Flammable gas |
| H222 | Extremely flammable aerosol |
| H223 | Flammable aerosol |
| H224 | Extremely flammable liquid and vapour |
| H225 | Highly flammable liquid and vapour |
| H226 | Flammable liquid and vapour |
| H227 | Combustible liquid |
| H228 | Flammable solid |
| H229 | Pressurized container: may burst if heated |
| H230 | May react explosively even in the absence of air |
| H231 | May react explosively even in the absence of air at elevated pressure and/or temperature |
| H240 | Heating may cause an explosion |
| H241 | Heating may cause a fire or explosion |
| H242 | Heating may cause a fire |
| H250 | Catches fire spontaneously if exposed to air |
| H251 | Self-heating; may catch fire |
| H252 | Self-heating in large quantities; may catch fire |
| H260 | In contact with water releases flammable gases which may ignite spontaneously |
| H261 | In contact with water releases flammable gas |
| H270 | May cause or intensify fire; oxidizer |
| H271 | May cause fire or explosion; strong oxidizer |
| H272 | May intensify fire; oxidizer |
| H280 | Contains gas under pressure; may explode if heated |
| H281 | Contains refrigerated gas; may cause cryogenic burns or injury |
| H290 | May be corrosive to metals |
Health hazards | |
| Code | Phrase |
| H300 | Fatal if swallowed |
| H301 | Toxic if swallowed |
| H302 | Harmful if swallowed |
| H303 | May be harmful if swallowed |
| H304 | May be fatal if swallowed and enters airways |
| H305 | May be harmful if swallowed and enters airways |
| H310 | Fatal in contact with skin |
| H311 | Toxic in contact with skin |
| H312 | Harmful in contact with skin |
| H313 | May be harmful in contact with skin |
| H314 | Causes severe skin burns and eye damage |
| H315 | Causes skin irritation |
| H316 | Causes mild skin irritation |
| H317 | May cause an allergic skin reaction |
| H318 | Causes serious eye damage |
| H319 | Causes serious eye irritation |
| H320 | Causes eye irritation |
| H330 | Fatal if inhaled |
| H331 | Toxic if inhaled |
| H332 | Harmful if inhaled |
| H333 | May be harmful if inhaled |
| H334 | May cause allergy or asthma symptoms or breathing difficulties if inhaled |
| H335 | May cause respiratory irritation |
| H336 | May cause drowsiness or dizziness |
| H340 | May cause genetic defects |
| H341 | Suspected of causing genetic defects |
| H350 | May cause cancer |
| H351 | Suspected of causing cancer |
| H360 | May damage fertility or the unborn child |
| H361 | Suspected of damaging fertility or the unborn child |
| H361d | Suspected of damaging the unborn child |
| H362 | May cause harm to breast-fed children |
| H370 | Causes damage to organs |
| H371 | May cause damage to organs |
| H372 | Causes damage to organs through prolonged or repeated exposure |
| H373 | May cause damage to organs through prolonged or repeated exposure |
Environmental hazards | |
| Code | Phrase |
| H400 | Very toxic to aquatic life |
| H401 | Toxic to aquatic life |
| H402 | Harmful to aquatic life |
| H410 | Very toxic to aquatic life with long-lasting effects |
| H411 | Toxic to aquatic life with long-lasting effects |
| H412 | Harmful to aquatic life with long-lasting effects |
| H413 | May cause long-lasting harmful effects to aquatic life |
| H420 | Harms public health and the environment by destroying ozone in the upper atmosphere |
Sorry,this product has been discontinued.
Home
* Country/Region
* Quantity Required :
* Cat. No.:
* CAS No :
* Product Name :
* Additional Information :
Total Compounds: mg
The concentration of the dissolution solution you need to prepare is mg/mL


